NVAX – Novavax, Inc.
NVAX — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
28.05
Margin Of Safety %
Put/Call OI Ratio
0.51
EPS Next Q Diff
-0.01
EPS Last/This Y
-3.27
EPS This/Next Y
0.38
Price
7.94
Target Price
13.75
Analyst Recom
2.62
Performance Q
-13.87
Upside
-769.2%
Beta
2.42
Ticker: NVAX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | NVAX | 8.91 | 0.55 | 0.66 | 233286 |
| 2026-07-14 | NVAX | 8.43 | 0.55 | 0.40 | 233670 |
| 2026-07-15 | NVAX | 8.42 | 0.57 | 0.58 | 235404 |
| 2026-07-16 | NVAX | 8.24 | 0.57 | 0.28 | 236586 |
| 2026-07-17 | NVAX | 8.22 | 0.56 | 0.11 | 238521 |
| 2026-07-20 | NVAX | 7.88 | 0.66 | 0.24 | 182785 |
| 2026-07-21 | NVAX | 8.07 | 0.65 | 0.25 | 190554 |
| 2026-07-22 | NVAX | 7.91 | 0.64 | 0.16 | 192465 |
| 2026-07-23 | NVAX | 7.82 | 0.63 | 0.32 | 195599 |
| 2026-07-24 | NVAX | 7.45 | 0.63 | 0.20 | 197201 |
| 2026-07-27 | NVAX | 7.5 | 0.62 | 0.25 | 195750 |
| 2026-07-28 | NVAX | 7.36 | 0.61 | 0.39 | 198252 |
| 2026-07-29 | NVAX | 7.33 | 0.61 | 0.30 | 200737 |
| 2026-07-30 | NVAX | 7.45 | 0.61 | 0.13 | 203005 |
| 2026-07-31 | NVAX | 7.32 | 0.60 | 0.34 | 204156 |
| 2026-08-03 | NVAX | 7.41 | 0.56 | 0.05 | 195416 |
| 2026-08-04 | NVAX | 7.66 | 0.52 | 0.10 | 204441 |
| 2026-08-05 | NVAX | 7.71 | 0.52 | 0.21 | 205530 |
| 2026-08-06 | NVAX | 7.74 | 0.52 | 0.16 | 207628 |
| 2026-08-07 | NVAX | 7.93 | 0.51 | 0.37 | 209103 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | NVAX | 8.91 | -100.0 | - | -0.47 |
| 2026-07-14 | NVAX | 8.42 | -100.0 | - | -0.47 |
| 2026-07-15 | NVAX | 8.43 | -100.0 | - | -0.47 |
| 2026-07-16 | NVAX | 8.24 | -100.0 | - | -0.47 |
| 2026-07-17 | NVAX | 8.21 | -100.0 | - | -0.47 |
| 2026-07-20 | NVAX | 7.88 | -100.0 | - | -0.47 |
| 2026-07-21 | NVAX | 8.07 | -100.0 | - | -0.47 |
| 2026-07-22 | NVAX | 7.92 | -100.0 | - | -0.47 |
| 2026-07-23 | NVAX | 7.83 | -100.0 | - | -0.47 |
| 2026-07-24 | NVAX | 7.46 | -100.0 | - | -0.47 |
| 2026-07-27 | NVAX | 7.49 | -100.0 | - | -0.47 |
| 2026-07-28 | NVAX | 7.36 | -100.0 | - | -0.47 |
| 2026-07-29 | NVAX | 7.34 | -100.0 | - | -0.47 |
| 2026-07-30 | NVAX | 7.45 | -100.0 | - | -0.47 |
| 2026-07-31 | NVAX | 7.31 | -100.0 | - | -0.47 |
| 2026-08-03 | NVAX | 7.42 | -100.0 | - | -0.47 |
| 2026-08-04 | NVAX | 7.42 | -100.0 | - | -0.47 |
| 2026-08-05 | NVAX | 7.71 | -100.0 | - | -0.47 |
| 2026-08-06 | NVAX | 7.74 | -100.0 | - | -0.47 |
| 2026-08-07 | NVAX | 7.94 | -100.0 | - | -0.55 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | NVAX | 0.00 | -1.34 | 29.33 |
| 2026-07-14 | NVAX | 0.00 | -1.34 | 29.33 |
| 2026-07-15 | NVAX | 0.00 | -1.34 | 29.33 |
| 2026-07-16 | NVAX | 0.00 | -1.34 | 29.33 |
| 2026-07-17 | NVAX | 0.00 | -1.34 | 29.33 |
| 2026-07-20 | NVAX | 0.00 | -1.34 | 29.33 |
| 2026-07-21 | NVAX | 0.00 | -1.34 | 29.33 |
| 2026-07-22 | NVAX | 0.00 | -1.34 | 29.33 |
| 2026-07-23 | NVAX | 0.00 | -1.34 | 29.33 |
| 2026-07-24 | NVAX | 0.00 | -1.34 | 29.33 |
| 2026-07-27 | NVAX | 0.00 | -1.36 | 28.06 |
| 2026-07-28 | NVAX | 0.00 | -1.36 | 28.06 |
| 2026-07-29 | NVAX | 0.00 | -1.36 | 28.06 |
| 2026-07-30 | NVAX | 0.00 | -1.36 | 28.06 |
| 2026-07-31 | NVAX | 0.00 | -1.36 | 28.06 |
| 2026-08-03 | NVAX | 0.00 | -1.52 | 28.05 |
| 2026-08-04 | NVAX | 0.00 | -1.52 | 28.05 |
| 2026-08-05 | NVAX | 0.00 | -1.52 | 28.05 |
| 2026-08-06 | NVAX | 0.00 | -1.52 | 28.05 |
| 2026-08-07 | NVAX | 0.00 | -1.52 | 28.05 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.06
Avg. EPS Est. Current Quarter
-0.38
Avg. EPS Est. Next Quarter
-0.07
Insider Transactions
Institutional Transactions
-1.52
Beta
2.42
Average Sales Estimate Current Quarter
52
Average Sales Estimate Next Quarter
100
Fair Value
Quality Score
33
Growth Score
23
Sentiment Score
83
Actual DrawDown %
97.1
Max Drawdown 5-Year %
-98.6
Target Price
13.75
P/E
Forward P/E
PEG
P/S
3.16
P/B
P/Free Cash Flow
EPS
-1.52
Average EPS Est. Cur. Y
-0.55
EPS Next Y. (Est.)
-0.18
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-59.87
Relative Volume
1.24
Return on Equity vs Sector %
33.4
Return on Equity vs Industry %
49.4
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.08
EBIT Estimation
◆
NVAX
Healthcare
$7.95
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
46.7
Range 1M
31.3%
Sup Dist
5%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-124.6%
EPS NY
65.2%
52W%
30.2%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+73% upside
Upside
+73%
Quality
33
NVAX — P/E HistoricalBiotechnology
Novavax, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 749
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
NVAX
Latest News
—
Caricamento notizie per NVAX…
stock quote shares NVAX – Novavax, Inc. Stock Price stock today
news today NVAX – Novavax, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NVAX – Novavax, Inc. yahoo finance google finance
stock history NVAX – Novavax, Inc. invest stock market
stock prices NVAX premarket after hours
ticker NVAX fair value insiders trading